Movano Inc.

NasdaqCM MOVE

Movano Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2024

Movano Inc. Capital Expenditure is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Movano Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -72.00 K, a 77.98% change year over year.
  • Movano Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -327.00 K, a -1.55% change year over year.
  • Movano Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -322.00 K, a -2,376.92% change year over year.
  • Movano Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -13.00 K.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
NasdaqCM: MOVE

Movano Inc.

CEO Dr. John Mastrototaro Ph.D.
IPO Date March 23, 2021
Location United States
Headquarters 6800 Koll Center Parkway
Employees 30
Sector Health Care
Industries
Description

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

Similar companies

IRIX

IRIDEX Corporation

USD 1.61

-1.23%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SSKN

STRATA Skin Sciences, Inc.

USD 2.95

0.00%

TNON

Tenon Medical, Inc.

USD 1.67

-3.47%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

LIVN

LivaNova PLC

USD 47.63

0.66%

ELMD

Electromed, Inc.

USD 31.05

1.90%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

LNSR

LENSAR, Inc.

USD 7.66

-4.96%

StockViz Staff

January 15, 2025

Any question? Send us an email